313491-20-2

Basic information

• Product Name: tert-butyl 4-(1-(benzyloxycarbonyl)-2-methoxy-2-oxoethylidene)piperidine-1-carboxylate
• Synonyms: tert-butyl 4-(1-(benzyloxycarbonyl)-2-methoxy-2-oxoethylidene)piperidine-1-carboxylate;Methyl 2-(1-Boc-4-piperidylidene)-2-(Cbz-amino)acetate
• CAS NO: 313491-20-2
• Molecular Formula: C₂₁H₂₈N₂O₆
• Molecular Weight: 389.44218
• Mol File: 313491-20-2.mol
• Article Data: 14

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-butyl 4-(1-(benzyloxycarbonyl)-2-methoxy-2-oxoethylidene)piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(1-(benzyloxycarbonyl)-2-methoxy-2-oxoethylidene)piperidine-1-carboxylate(313491-20-2)
• EPA Substance Registry System: tert-butyl 4-(1-(benzyloxycarbonyl)-2-methoxy-2-oxoethylidene)piperidine-1-carboxylate(313491-20-2)

Safety Data

• Hazardous Substances Data: 313491-20-2(Hazardous Substances Data)

Usage

General Description

"Tert-butyl 4-(1-(benzyloxycarbonyl)-2-methoxy-2-oxoethylidene)piperidine-1-carboxylate" is a chemical compound with a complex structure. It contains a piperidine ring with a carboxylate group attached, as well as a tert-butyl group. Additionally, it contains a benzyl group and a methoxy group, as well as an oxoethylidene group. tert-butyl 4-(1-(benzyloxycarbonyl)-2-methoxy-2-oxoethylidene)piperidine-1-carboxylate is commonly used in organic synthesis and medicinal chemistry research due to its potential to serve as a precursor or intermediate in the synthesis of pharmaceutical compounds. The presence of the benzyloxycarbonyl group suggests that it may have applications in protecting amine groups during chemical reactions. Overall, "tert-butyl 4-(1-(benzyloxycarbonyl)-2-methoxy-2-oxoethylidene)piperidine-1-carboxylate" is a versatile and potentially useful compound in the field of organic chemistry.

Upstream product

• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 100945-15-1 N-(benzyloxycarbonyl)phosphonoglycine trimethyl ester 

Downstream Products

• 368866-12-0 4-(amino-methoxycarbonyl-methyl)-piperidine-1-carboxylic acid tert-butyl ester 
• 400888-21-3 4-((R)-benzyloxycarbonylamino-methoxycarbonyl-methyl)piperidine-1-carboxylic acid tert-butyl ester 
• 400888-22-4 4-((R)-benzyloxycarbonylamino-carboxy-methyl)piperidine-1-carboxylic acid tert-butyl ester 
• 177702-21-5 4-((R)-amino-carboxy-methyl)piperidine-1-carboxylic acid tert-butyl ester 
• 357413-57-1 (4'-methoxy-biphenyl-4-sulfonylamino)-[1-(2-methoxy-ethoxycarbonyl)-piperidin-4-yl]-acetic acid methyl ester 

Relevant articles and documents

Preparation method of 2-amino-2-(1-methyl-4-piperidyl)ethanol

The invention discloses a preparation method of 2-amino-2-(1-methyl-4-piperidyl) ethanol. The preparation method comprises the following steps: reacting 2-methyl-2-propyl-4-(1-amino-2-methoxy-2-oxoethyl)-1-piperidinecarboxylate (a compound II) with benzyl bromide under the action of an alkali 1 to generate a compound III; dissolving the compound III in an organic solvent, and generating a compound IV under the action of a reducing agent; and removing benzyl from the compound IV under the action of a catalyst/hydrogen to generate a compound I.

TETRACYCLIC HETEROCYCLE COMPOUNDS FOR TREATING HEPATITIS C VIRAL INFECTION

Tetracyclic heterocycle compounds of formula (I) and pharmaceutically acceptable salts thereof are provided, wherein A, A', G, R1, R15, U, V, V', W, W, X, X', Y and Y' are as defined in the invention. The pharmaceutical compositions comprising these compounds and the use of the compounds for treating hepatitis C virus (HCV) infection are also provided.

TETRACYCLIC INDOLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

The present invention relates to novel Tetracyclic Indole Derivatives of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, A', G, R1, R15, U, V, V', X, X', Y and Y' are as defined herein. The present invention also relates to compositions comprisingat least one Tetracyclic Indole Derivative, and methods of using the Tetracyclic Indole Derivatives for treating or preventing HCV infection in a patient.